首页> 外文期刊>Microbiological Research >The complete genome of lytic Salmonella phage vB_SenM-PA13076 and therapeutic potency in the treatment of lethal Salmonella Enteritidis infections in mice
【24h】

The complete genome of lytic Salmonella phage vB_SenM-PA13076 and therapeutic potency in the treatment of lethal Salmonella Enteritidis infections in mice

机译:裂解沙门氏菌的完整基因组VB_SENM-PA13076及治疗小鼠致致死性肠道感染的治疗效力

获取原文
获取原文并翻译 | 示例
           

摘要

S. Enteritidis continues to be the most common pathogen of farm animals and a major public health burden worldwide. Using bacteriophages is a potential alternative to antibiotics against S. Enteritidis infection. In this study, the genome analysis of the lytic phage vB_SenM-PA13076 (PA13076) infecting S. Enteritidis revealed a linear, double-stranded DNA genome, which comprised of 52,474 bp and contained 69 ORFs. It belongs to the order Caudovirales; family Myoviridae, genus unclassified. The genes coded for DNA packaging, phage structural proteins, lysis components, DNA recombination, regulation, modification, and replication. No bacterial virulence or drug-resistance genes were detected. The phage PA13076 protected mice from a lethal dose of S. Enteritidis 13076(Amp) (5 x 10(8) CFU) by reducing the concentration of bacterial cells in blood, intestine, liver, spleen, and kidney. The phage PA13076 achieved at least 2.5 log reductions of S. Enteritidis cells in infected mice within 24 h (P < 0.05) when compared to the organs of control mice. The data also indicated that phage PA13076 could rapidly enter the blood and four organs of infected mice, remaining therein at concentrations of > 10(4) PFU/g for at least 72 h. These results show that phage PA13076 has definite potential as an antibacterial therapeutic agent for attenuating S. Enteritidis infections.
机译:S. Enteritidis仍然是农场动物最常见的病原体和全球主要的公共卫生负担。使用噬菌体是针对S.肠炎患者感染的抗生素的潜在替代品。在该研究中,裂解S.肠杆菌的裂解噬菌体VB_SENM-PA13076(PA13076)的基因组分析显示出直线的双链DNA基因组,其包含52,474bp和含有69个ORF。它属于剖宫产的顺序;家族myoviridae,属未分类。编码用于DNA包装,噬菌体结构蛋白,裂解组分,DNA重组,调节,改性和复制的基因。未检测到细菌毒力或耐药基因。通过降低血液,肠,肝,脾细胞和肾脏的细菌细胞浓度,噬菌体PA13076受到肠道剂量的致死剂量的致死剂量的小鼠(5×10(8)CFU)。与对照小鼠的器官相比,噬菌体PA13076在24小时内(P <0.05)内的感染小鼠中的S.肠炎虫细胞的至少2.5对数。该数据还表明,噬菌体PA13076可以迅速进入感染小鼠的血液和四个器官,其浓度> 10(4)PFU / g至少72小时。这些结果表明,噬菌体PA13076具有明确的抗菌治疗剂,用于衰减肠炎肠道感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号